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Abstract 
Xenobiotic metabolism is an active research topic but the limited amount of openly available high-quality biotrans-
formation data constrains predictive modeling. Current database often default to commonly available information: 
which enzyme metabolizes a compound, but neither experimental conditions nor the atoms that undergo metaboli-
zation are captured. We present XMetDB, an open access database for drugs and other xenobiotics and their respec-
tive metabolites. The database contains chemical structures of xenobiotic biotransformations with substrate atoms 
annotated as reaction centra, the resulting product formed, and the catalyzing enzyme, type of experiment, and 
literature references. Associated with the database is a web interface for the submission and retrieval of experimental 
metabolite data for drugs and other xenobiotics in various formats, and a web API for programmatic access is also 
available. The database is open for data deposition, and a curation scheme is in place for quality control. An extensive 
guide on how to enter experimental data into is available from the XMetDB wiki. XMetDB formalizes how biotransfor-
mation data should be reported, and the openly available systematically labeled data is a big step forward towards 
better models for predictive metabolism.
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Background
Xenobiotic metabolism covers the biochemical modifica-
tion of drugs and xenobiotics by living organisms. These 
biotransformations are usually carried out by specialized 
enzymatic systems such as the cytochrome P450s and the 
UDP-glucuronosyltransferases [1], with the aim to make 
compounds more soluble and more easily excreted from 
the body.
Understanding how xenobiotic metabolism occurs in 
the human body is important in two fields particularly: 
drug discovery and toxicology. In drug discovery, one 
needs to understand what metabolites of a potential drug 
are formed to be able to study what effects they have [2]. 
Occasionally, some metabolites are more potent than the 
drug itself. For example, cyclophosphamide is a prodrug 
that is implicated to be activated by P450s  [3]. Further-
more, metabolism can cause unwanted side effects, for 
example by interfering with the potential use of other 
drugs by inhibiting certain enzymes and, for exam-
ple, change blood concentrations of drugs  [4]. In the 
field of toxicology, understanding the metabolism of all 
types of chemicals is important, even if the compounds 
themselves are not toxic, and it is their metabolites that 
cause the toxic effects. This also makes it important to 
understand metabolism when building in silico models 
that predict toxicity, as the molecular properties of the 
original compound and its metabolites may differ signifi-
cantly. The evaluation of the metabolic fate and metabo-
lism similarity of target and analog compounds in the 
context of read-across is an essential part of the frame-
work for toxicological assessment proposed by Wu et al. 
[5] and relevant methods and tools are emphasized in a 
recent review on in-silico approaches for predicting tox-
icity [6].
The creation and validation of in silico models for pre-
dicting the metabolism of xenobiotics is an active field of 
research [7–17]. However, the available of suitable data is 
limited in two ways. First, relevant data used to construct 
these models are either locked away in proprietary and 
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commercial databases, such as the Accelrys Metabolite 
database (http://accelrys.com/products/collaborative-
science/databases/bioactivity-databases/biovia-metab-
olite.html), or is put together specifically for each new 
model  [14]. The availability of data in a public database 
accessible in an open format and curated by the scientific 
community would be a major step forward in decreasing 
the work required to create new models, and to enable 
comparisons of different models.
Second, the experiments to accurately link the meta-
bolic conversion to a specific enzyme are rare. Often 
microsomes and hepatocytes of animal and human ori-
gin are used [18], in which it cannot always fully be cer-
tain which enzyme really does the conversion. Currently, 
the most detailed experimental procedures used to ver-
ify which metabolites are formed use cDNA-expressed 
drug-metabolizing enzymes, followed by LC/MS analysis 
of the formed metabolites [19]. A further complication is 
that even when reference compounds of the metabolites 
are available in such studies, it is still not always possi-
ble to accurately identify at which atomic position the 
conversion happens, for example, of an aromatic ring 
hydroxylation reaction. Other types of experiments give 
information about the metabolism, but few studies give 
the full picture. Nevertheless, it is this precise record-
ing of experimental detail is critical, whatever the used 
method is.
Published data on xenobiotic metabolism, which may 
serve as an information source of a new database, are 
currently fragmented over many journals and publica-
tions, using different experiment types, and provided 
in different formats, conforming to different standards. 
There are several existing databases that contain infor-
mation relevant for xenobiotic metabolism, including 
DrugBank  [20], SuperCYP  [21], hDBMdb  [22], Metra-
base  [23], Human Metabolome Database (HMDB)  [24] 
and Transformer  [25]; Drugbank reports substrate—
product—enzyme, and while it includes references, these 
are typically to other database rather than primary lit-
erature; Transformer reports substrate—enzyme—refer-
ence, but not what the product is; Metrabase focuses on 
transporters and xenobiotic metabolism; HMDB lists the 
enzyme and literature but not the species the transforma-
tion was observed in, and, SuperCYP reports substrate—
product—enzyme. Importantly, these databases do not 
include atom–atom mapping which is crucial for building 
predictive models for site-of-metabolism. hDBMdb does 
not seem to be operational anymore. Further, none of the 
previously mentioned databases has an open application 
programming interface (API) for direct consumption in 
scripts and third party applications, making them less 
useful for large scale modeling [26–29]
Further, the commercially available databases are very 
expensive and sometimes contain unpublished data, 
leading to further literature studies to find validation data 
that can be used in publications. Also, since different for-
mats and standards are used across different labs, there is 
no consistent evaluation system for these kinds of mod-
els, resulting in published statistics that are not directly 
comparable between publications, e.g. mapping from 
mechanism to atoms that have not been performed in an 
identical fashion.
This lack of publicly available data has led to numerous 
repetitive literature searches for many academic research 
groups interested in metabolite prediction modeling. 
However, finding appropriate literature with enough 
detail is a challenge in itself. The knowledge about bio-
transformations is limited and reports about it are scat-
tered. Peer-reviewed literature is not the only source of 
information, nor does literature report all the details we 
want to capture. Anecdotal examples even shows lit-
erature citing conference posters and package inserts as 
primary sources [30]. Other literature includes FDA sub-
missions, but these too can provide only limited detail 
and may also lack information about products formed.
We here present XMetDB—an open access database 
for xenobiotic metabolism implemented as an online sys-
tem for deposition and sharing of experimental data. It is 
the first database that contain atom reaction center map-
ping and also includes a new reporting standard for this, 
with data and software available under Open licenses.
Results
XMetDB consists of a database, an application layer for 
interacting with the database, and a user interface. The 
core data stored in the database are Observations, which 
consists of an experimentally detected enzyme-catalyzed 
reaction of a substrate that yields a product. XMetDB 
contains the chemical structure of substrates and prod-
ucts, and also includes annotations of atoms which are 
affected by the metabolizing reaction, indicating experi-
mentally derived site-of-metabolism annotations. The 
experimental conditions are limited to the type of experi-
ment (one of enzymes, hepatocytes and microsomes) and 
enzymes involved. The species assumed is human. The 
initial design does not allow specifying the species, as 
the intention was to built a database for human metabo-
lism. Associated structured information includes uncer-
tainty of the atom mappings (either certain or uncertain), 
amount of product formed in the reaction (one of major, 
minor, or unknown), a literature reference, and com-
ments as free text. Enzymes, such as members of the 
Cytochrome P450 family, can be added separately and are 
linked out to UniProt via UniProt ID.
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In addition, each observation can be tagged as curated 
or not, and assigned free text comment.
All Observations have unique identifiers, for example 
the arbitrarily chosen entry XMETDB153 for the obser-
vation of the P450-mediated oxidation of quinoline into 
3-hydroxyquinoline by the CYP2E1 isoform, and com-
prises a metabolic transformation (substrate, product), 
the enzyme, a literature reference, and a categorization 
of the experiment with the enzyme identified by its name 
and UniProt identifier. The reference in the example is 
provided as free text, while increasingly the DOI is given 
instead of a textual reference.
Version 1.0 of XMetDB contains 162 observations from 
21 scientific papers from 14 journals, covering 117 chem-
ical structures and 95 enzymes.
Web interface
XMetDB provides two interfaces: an HTML-based 
interface for access via a web browser and aimed at 
humans, and an API set up for programmatic interac-
tion. The key features of the interfaces are: (1) browse 
and search for observations, (2) submit new observa-
tions, and (3) add and browse enzymes. The API is 
described later, and we first explain the graphical user 
interface.
Data querying
The principal way to browse the data in XMetDB is by 
listing all observations (see Fig. 1 for an example). The list 
shows observations paginated, and the number of obser-
vations shown can be changed from 10 to 20, 50, 100, and 
all observations. Alternatively, it is possible to browse 
the observations by enzyme, presenting a list of observa-
tions for a particular enzyme (see Fig. 2 for an example). 
Both lists can be sorted by any of the available columns 
and lead to individual observations, each with a unique 
identifier.
The user interfaces in XMetDB supports searching for 
observations by status, experiment type, enzyme, refer-
ence, XMETID, and allele. It is also possible to search for 
substrates and products by chemical similarity and sub-
structure using a structure diagram editor or by chemi-
cal identifier (CAS, Chemical Name, SMILES, InChI or 
SMARTS for a substructure search). The resulting list of 
structures is ordered by similarity, clicking the folder icon 
returns a list of observations involving this structure.
Fig. 1 Browsing observations in XMetDB. When browsing all or a subset of observations, the table shows the chemical structures of substrate and 
product together with other data and metadata
Page 4 of 8Spjuth et al. J Cheminform  (2016) 8:47 
Data entry
Submission of a new observation works as a two-step 
procedure: (1) Enter substrate and product structures 
and meta-data describing the experiment; (2) Select 
atom mappings for the reaction, which is included to 
enable more accurate site-of-metabolism modeling. All 
atom mappings used in XMetDB should be annotated as 
either Certain or Uncertain, where certain means that as 
far as possible it is known at which atom (or atoms) the 
reaction is initiated. To help the users, a large collection 
of metabolic reactions and their corresponding sites of 
metabolism have been collected, and are available in the 
XMetDB wiki: http://www.xmetdb.org/wiki/, together 
with an extensive guide for how to enter experimental 
data. An example of hydroxylation of aromatic carbon 
atoms by cytochromes P450 is shown in Fig. 3.
Data curation
XMetDB supports a curator role, with the purpose to 
ensure high quality data in the database. Data that has 
been verified by a curator besides the original submit-
ter has been validated by at least one additional person, 
and the curator has been verified by the administra-
tors as an expert on biotransformations for at least one 
enzyme family. The curators can edit all observations 
but not essential info such as experiment and enzymes. 
The curators can change atom highlighting and com-
ments and typos in references. The curators can set the 
flag curated to yes for any observations. The users may 
Fig. 2 Browsing enzymes in XMetDB. When browsing all or a subset of enzymes, the table shows the Code, Name, UniProt ID, and optionally allele 
for each entry
Fig. 3 Examples of how biotransformations should be reported. This 
example shows the atoms defined as reaction centra indicated in 
blue. Top Hydroxylation of aromatic carbons. Bottom Hydroxylation of 
aromatic carbons coupled with halogen migration
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indicate their availability to act as a curator, but the role 
must be assigned by an administrator.
Data export
Lists of observations, such as the results of a query, can 
be exported as column separated values (CSV) or struc-
ture data file (SDF) formats (see Table  1 for details). 
CSV files include the observations along with chemical 
structures represented as SMILES and InChI, with col-
umn names as listed in Table 2. SDF files includes chemi-
cal structures with the observations data and metadata 
stored as a set of SDF tags (an example file is given in 
Additional file 1). Single reaction entries can be exported 
in the GPML format, which is the XML language used by 
WikiPathways for storage of pathways.
Web API
The XMetDB database exposes an open Application Pro-
gram Interface (API) that allows the data to be accessed 
programmatically by software applications (e.g. workflow 
engines, scripts) and other web services [31].
The main XMetDB API components are observations, 
enzymes, and chemical structures. Every component is 
assigned an unique URI, e.g. http://xmetdb.org/protocol/
XMETDB1 for an observation. The API follows RESTful 
principles, where each component (the term in the REST 
vocabulary is a “resource”) allows only four operations:
  • GET—to retrieve the content of the resource
  • e.g. GET http://xmetdb.org/protocol/XMETDB1
  • PUT—update the content of the resource
  • e.g. PUT (some data to) http://xmetdb.org/proto-
col/XMETDB1
  • POST—-create a new resource
  • e.g. POST (representation of a new resource to) 
http://xmetdb.org/protocol, the result is e.g. 
http://xmetdb.org/protocol/XMETDB2
  • DELETE—remove the resource
  • e.g. after DELETE http://xmetdb.org/protocol/
XMETDB1 this resource will no more exist
The Web API is described extensively in XMetDB Wiki 
at: http://www.xmetdb.org/wiki/API.
Implementation
XMetDB is implemented as a Java Web application 
(source code at https://github.com/xmetdb/xmetdb-
server), which is accessible via a web browser and pro-
grammatically via a REST API. The web application is 
using the Restlet framework (http://restlet.com/pro-
jects/restlet-framework/) and is deployable in a com-
patible servlet container. The XMetDB user interface 
is built with FreeMarker templates  http://freemarker.
incubator.apache.org/ and JavaScript, interacting with 
the server side and the database through the REST API. 
Table 1 Download formats
Format Media type HTTP header URI parameter
CSV text/csv Accept: text/csv ?media=text/csv
SD file chemical/x-mdl-sdfile Accept: chemical/x-mdl-sdfile ?media=chemical/x-mdl-sdfile
Table 2 Export column headers
Name Description
URI XMetDB observation URI
Identifier XMetDB observation identifier
Substrate SMILES SMILES of the substrate structure
Substrate InChI InChI of the substrate structure
Product SMILES SMILES of the product structure
Product InChI InChI of the product structure
Product amount The product amount. One of Major, Minor or Unknown
Experiment type The experiment. One of Hepatocytes, Microsomes, Enzymes
Enzyme code Enzyme code
Enzyme name Enzyme name
UniProt Enzyme UniProt ID
Reference The publication from which the data is taken, either as a DOI or as a plain text reference
Comment Free text comment
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The experimental data is stored in a MySQL database, 
the database schema is available at https://github.com/
xmetdb/xmetdb-server/blob/master/xmet-db/src/main/
resources/org/xmetdb/xmet/protocol/db/sql/xmetdb.sql.
The core requirement to store and query chemical 
structures and allow interactive editing of atom–atom 
mapping is enabled through interaction with a separate 
web application (AMBIT 2.4.11  [32]), which provides a 
web service interface to a chemical structure database. 
The AMBIT package enables upload or retrieval of indi-
vidual structures or entire datasets, searching by identi-
fiers, similarity, and substructure [33]. In AMBIT, each 
XMetDB observation corresponds to a dataset, where the 
substrate and the products are stored. The atom–atom 
mapping are stored as OpenTox features, unique to the 
”observation” dataset and associated with the chemical 
structure  [32]. AMBIT follows the REST approach to 
representation of all resources, for example the chemi-
cal structure diagram can be retrieved by requesting the 
proper MIME type (i.e. image/png) of a chemical struc-
ture resource. The structure diagram rendering was 
extended to generate an image map along with the image, 
delineating the atoms. The image map is used to display 
highlighted atoms and enables the interactive atom selec-
tion. An alternative implementation with SVG rendering 
was considered, but was not selected, as at the begin-
ning of XMetDB implementation the browser SVG sup-
port was limited. As a structure diagram editor the freely 
available ChemDoodle 2D Sketcher  [34] is used (JavaS-
cript). The 2D Sketcher is embedded in a separate frame, 
as a workaround of the conflicting version of jQuery 
dependencies at the time of the development.
From a deployment perspective, XMetDB consists of 
two web containers: xmetdb.war and ambit2.war, avail-
able both as pre-deployed online web services at http://
xmetdb.org, and as a downloadable web application 
which can be deployed in a compatible servlet container. 
The chemical structures and datasets are represented as 
described in [33], enhanced with JSON representation to 
facilitate the user interface implementation (http://ambit.
sourceforge.net/api.html). The supported data formats 
are JSON and RDF (RDF/XML and RDF/N3) and asyn-
chronous jobs are handled according to OpenTox API 
version 1.2 specifications [32].
Users and roles
The XMetDB application supports the following user 
roles: (1) regular user, (2) curator and (3) administrator. 
A regular user is any registered user who is logged in; and 
can add observations to the database, save searches as 
alerts, edit the user profile, and flag availability as cura-
tors. A curator is a regular user who has been approved 
as a curator. Beyond regular user rights, a curator can 
approve that data submitted by other users has been 
added in a consistent manner, and verify that the atom 
mappings and references are correct. As part of the cura-
tion process he/she can also edit atom mappings, and 
metadata of an observation. An administrator is a curator 
with additional rights (to grant the curator role to other 
users, to modify the enzyme list, delete observations, 
modify user information etc.). Searching and brows-
ing the observations as well as exporting data through 
the web interface or API does not require the user to be 
logged in.
Discussion and conclusions
Extracting biotransformation data from literature is a 
cumbersome process, and crowdsourcing initiatives are 
needed in order to propel scientific discoveries and ena-
ble computational model building. The aim of XMetDB 
is to provide scientists with a public repository where 
xenobiotic metabolism data can be uploaded, shared, 
and integrated with other observations. Other databases 
related to metabolism do not include atom–atom map-
ping, and in this manuscript we propose a formalization 
of how xenobiotic metabolism data should be reported 
in order to improve computational model building. We 
acknowledge here, however, that current experimental 
methods may not always provide all the detail we ask 
to be reported. The open access philosophy of XMetDB 
allows for any content to be uploaded, and a curation 
system allows for curators to ensure that the database 
contents are of high quality. XMetDB hence provides 
the means for the community to collectively build up 
a knowledge base over time, and it is our hope that the 
community will adopt the system and deposit annotated 
metabolism data upon publication in scientific journals. 
For the future we also envision to import reaction data 
from other databases or possibly via text mining, which 
could encourage reporting and investigations on atom–
atom mapping.
The advanced search functions of XMetDB allow for 
querying substrates and products by chemical structure 
and various types of metadata using the web portal and 
also the programmatic API from third party applications 
and scripts. An example of an external collaborator that 
has chosen to support XMetDB is the  WikiPathways 
project  [35], which contributed code to support export-
ing data in GPML format [36]. The implementation with 
an available REST API with JSON serialization enables 
building graphical summaries of the data, development 
of JavaScript widgets, programmatic interaction and 
user interfaces beyond the current XMetDB web pages 
implementation.
The publicly available systematically labeled data in 
XMetDB will be a big step forward towards improved 
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models for predictive metabolism. Future plans include 
to integrate XMetDB in Bioclipse  [37] and expand the 
content with more data.
Authors’ contributions
OS, PR and NJ: Original idea, database and GUI design. EW, CE: Experimental 
data and interpretations. All authors read and approved the final manuscript.
Author details
1 Department of Pharmaceutical Biosciences and Science for Life Labora-
tory, Uppsala University, 75124 Uppsala, Sweden. 2 Department of Drug 
Design and Pharmacology, University of Copenhagen, Universitetsparken 
2, 2100 Copenhagen, Denmark. 3 Department of Bioinformatics - BiGCaT, 
Maastricht University, P.O. Box 616, UNS50 Box 19, 6200 MD Maastricht, The 
Netherlands. 4 IdeaConsult Ltd, 4 A.Kanchev str., 1000 Sofia, Bulgaria. 
Acknowlegements
Funding was received from Stiftelsen Olle Engkvist Byggmästare, and the 
Swedish strategic research program eSSENCE. During the XMetDB project, 
we were shocked by the tragic death of Patrik Rydberg. We would here like to 
acknowledge his scientific contributions in the field of xenobiotic metabolism 
and will continue the XMetDB project in his memory.
Competing interests
The authors declare that they have no competing interests.
Availability
XMetDB is available at http://www.xmetdb.org. The data is available under the 
CC-BY license while the software is licensed under the LGPL.
Received: 30 March 2016   Accepted: 4 September 2016
References
 1. Testa B, Pedretti A, Vistoli G (2012) Reactions and enzymes in the metabo-
lism of drugs and other xenobiotics. Drug Discov Today 17(11–12):549–60
 2. Claesson A, Spjuth O (2013) On mechanisms of reactive metabolite 
formation from drugs. Mini Rev Med Chem 13(5):9–720
 3. Huttunen KM, Raunio H, Rautio J (2011) Prodrugs—from serendipity to 
rational design. Pharmacol Rev 63(3):750–771
 4. Ito K, Iwatsubo T, Kanamitsu S, Ueda K, Suzuki H, Sugiyama Y (1998) Pre-
diction of pharmacokinetic alterations caused by drug–drug interactions: 
metabolic interaction in the liver. Pharmacol Rev 50(3):387–412
 5. Wu S, Blackburn K, Amburgey J, Jaworska J, Federle T (2010) A framework 
for using structural, reactivity, metabolic and physicochemical similarity 
to evaluate the suitability of analogs for SAR-based toxicological assess-
ments. Regul Toxicol Pharmacol 56(1):67–81
 6. Patlewicz GY, Fitzpatrick J (2015) Current and future perspectives on 
the development, evaluation and application of in silico approaches for 
predicting toxicity. Chem Res Toxicol 5:00388
 7. Rostkowski M, Spjuth O, Rydberg P (2013) WhichCyp: prediction of 
cytochromes P450 inhibition. Bioinformatics 29(16):2051–2052
 8. Kirchmair J, Williamson MJ, Tyzack JD, Tan L, Bond PJ, Bender A, Glen RC 
(2012) Computational prediction of metabolism: sites, products, SAR, P450 
enzyme dynamics, and mechanisms. J Chem Inf Model 52(3):48–617
 9. Kirchmair J, Bender A, Kubinyi H, Folkers G (2014) Drug metabolism 
prediction. Methods and principles in medicinal chemistry, vol 63. Wiley, 
Weinheim
 10. Kirchmair J, Göller AH, Lang D, Kunze J, Testa B, Wilson ID, Glen RC, Schnei-
der G (2015) Predicting drug metabolism: experiment and/or computa-
tion? Nat Rev Drug Discov 14(6):387–404. doi:10.1038/nrd4581
Additional file
Additional file 1. Example of exported SDF file from XMetDB.
 11. Carlsson L, Spjuth O, Adams S, Glen RC, Boyer S (2010) Use of historic 
metabolic biotransformation data as a means of anticipating metabolic 
sites using MetaPrint2D and Bioclipse. BMC Bioinform 11:362
 12. Piechota P, Cronin MTD, Hewitt M, Madden JC (2013) Pragmatic 
approaches to using computational methods to predict xenobiotic 
metabolism. J Chem Inf Model 53(6):92–1282
 13. Rudik AV, Dmitriev AV, Lagunin AA, Filimonov DA, Poroikov VV (2014) 
Metabolism site prediction based on xenobiotic structural formulas and 
pass prediction algorithm. J Chem Inf Model 54(2):498–507
 14. Rydberg P, Olsen L (2012) Ligand-based site of metabolism prediction for 
cytochrome P450 2D6. ACS Med Chem Lett 3(1):69–73
 15. Kolanczyk RC, Schmieder P, Jones WJ, Mekenyan OG, Chapkanov A, 
Temelkov S, Kotov S, Velikova M, Kamenska V, Vasilev K, Veith GD (2012) 
MetaPath: an electronic knowledge base for collating, exchanging and 
analyzing case studies of xenobiotic metabolism. Regul Toxicol Pharma-
col RTP 63(1):84–96
 16. Rudik A, Dmitriev A, Lagunin A, Filimonov D, Poroikov V (2015) SOMP: 
web server for in silico prediction of sites of metabolism for drug-like 
compounds. Bioinformatics 31(12):2046–2048
 17. Lapins M, Worachartcheewan A, Spjuth O, Georgiev V, Prachayasittikul 
V, Nantasenamat C, Wikberg JES (2013) A unified proteochemometric 
model for prediction of inhibition of cytochrome P450 isoforms. PLoS 
ONE 8(6):66566
 18. Iwatsubo T, Hirota N, Ooie T, Suzuki H, Shimada N, Chiba K, Ishizaki 
T, Green CE, Tyson CA, Sugiyama Y (1997) Prediction of in vivo drug 
metabolism in the human liver from in vitro metabolism data. Pharmacol 
Ther 73(2):147–171
 19. Ekins S, Ring BJ, Grace J, McRobie-Belle DJ, Wrighton SA (2000) Present 
and future in vitro approaches for drug metabolism. J Pharmacol Toxicol 
Methods 44(1):313–324
 20. Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, Chang 
Z, Woolsey J (2006) DrugBank: a comprehensive resource for in silico drug 
discovery and exploration. Nucleic Acids Res 34:72–668 (Database issue)
 21. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guen-
ther S, Winnenburg R, Schroeder M, Preissner R (2010) SuperCYP: a com-
prehensive database on cytochrome P450 enzymes including a tool for 
analysis of CYP–drug interactions. Nucleic Acids Res 38:43–237 (Database 
issue)
 22. Erhardt PW (2003) A human drug metabolism database: potential roles in 
the quantitative predictions of drug metabolism and metabolism-related 
drug–drug interactions. Curr Drug Metab 4(5):22–411
 23. Mak L, Marcus D, Howlett A, Yarova G, Duchateau G, Klaffke W, Bender A, 
Glen RC (2015) Metrabase: a cheminformatics and bioinformatics data-
base for small molecule transporter data analysis and (Q)SAR modeling. J 
Cheminform 7:31. doi:10.1186/s13321-015-0083-5
 24. Wishart DS, Jewison T, Guo AC, Wilson M, Knox C, Liu Y, Djoumbou Y, Man-
dal R, Aziat F, Dong E, Bouatra S, Sinelnikov I, Arndt D, Xia J, Liu P, Yallou F, 
Bjorndahl T, Perez-Pineiro R, Eisner R, Allen F, Neveu V, Greiner R, Scalbert 
A (2013) HMDB 3.0—the human metabolome database in 2013. Nucleic 
Acids Res 41:7–801. doi:10.1093/nar/gks1065 (Database issue)
 25. Hoffmann MF, Preissner SC, Nickel J, Dunkel M, Preissner R, Preissner 
S (2014) The Transformer database: biotransformation of xenobiotics. 
Nucleic Acids Res 42:7–1113 (Database issue)
 26. Jeliazkova N (2012) Web tools for predictive toxicology model building. 
Expert Opin Dug Metab Toxicol 8(5):1–11
 27. Frey JG, Bird CL (2013) Cheminformatics and the semantic web: adding 
value with linked data and enhanced provenance. Wiley Interdiscip Rev 
Comput Mol Sci 3(5):465–481
 28. Goldmann D, Montanari F, Richter L, Zdrazil B, Ecker GF (2014) Exploit-
ing open data: a new era in pharmacoinformatics. Future Med Chem 
6(5):503–14
 29. Williams AJ, Harland L, Groth P, Pettifer S, Chichester C, Willighagen EL, 
Evelo CT, Blomberg N, Ecker G, Goble C, Mons B (2012) Open PHACTS: 
semantic interoperability for drug discovery. Drug Discov Today 
17(21–22):1188–98
 30. DeLeon A, Patel NC, Lynn Crismon M, Aripiprazole A (2004) A compre-
hensive review of its pharmacology, clinical efficacy, and tolerability. Clin 
Ther 666(5):26–649
 31. Willighagen EL, Jeliazkova N, Hardy B, Grafström RC, Spjuth O (2011) 
Computational toxicology using the OpenTox application programming 
interface and Bioclipse. BMC Res Notes 4:487
Page 8 of 8Spjuth et al. J Cheminform  (2016) 8:47 
 32. Jeliazkova N, Jeliazkov V (2011) AMBIT RESTful web services: an imple-
mentation of the OpenTox application programming interface. J Chemin-
form 3:18
 33. Jeliazkova N, Kochev N (2011) AMBIT-SMARTS: efficient searching of 
chemical structures and fragments. Mol Inform 30(8):707–720
 34. Burger M (2015) ChemDoodle web components: HTML5 toolkit for 
chemical graphics, interfaces, and informatics. J Cheminform 7(1):1–7
 35. Pico AR, Kelder T, van Iersel MP, Hanspers K, Conklin BR, Evelo C (2008) 
WikiPathways: pathway editing for the people. PLoS Biol 6(7):184
 36. Kutmon M, Riutta A, Nunes N, Hanspers K, Willighagen EL, Bohler A, 
Mélius J, Waagmeester A, Sinha SR, Miller R, Coort SL, Cirillo E, Smeets 
B, Evelo CT, Pico AR (2016) WikiPathways: capturing the full diversity of 
pathway knowledge. Nucleic Acids Res 44(D1):488–494
 37. Spjuth O, Helmus T, Willighagen EL, Kuhn S, Eklund M, Wagener J, 
Murray-Rust P, Steinbeck C, Wikberg JES (2007) Bioclipse: an open source 
workbench for chemo- and bioinformatics. BMC Bioinform 8:59
